Phase 3Recruiting
A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid
A Phase III Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid in Patients with Hyperlipidemia Not Adequately Controlled by Statins
- Sponsor
- Gan & Lee Pharmaceuticals. (Industry)
- Enrolment
- 240 planned
- Conditions
- Primary Hyperlipidemia
- Interventions
- Bempedoic Acid Tablet; Placebo
- Ages
- adults, older adults
- Registry
- NCT06780410
Full record on ClinicalTrials.gov
From the registry
This trial is a phase III study to evaluate the efficacy , tolerability, and safety of Bempedoic Acid Tablets in patients with hyperlipidemia not adequately controlled by Statins.
Primary outcomes
- Percentage change from baseline in LDL-C levels at Week 12
History
Primary completion
Registered
Started